About Imris (OTCMKTS:IMRSQ)
Imaging Canada Liquidating Corp, formerly IMRIS Inc (IMRIS), is a Canada-based company, which designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment. It can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in various configurations. IMRIS sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. Its VISIUS iMRI provides imaging using Siemens 1.5T (tesla) and 3T MR core technology to enable imaging capabilities, including spectroscopy, fMRI and DTI. Its SYMBIS Surgical System is an MR and CT-compatible image guided surgical robot. Its VISIUS iCT is a multifunctional surgical theater that brings CT image quality with low dose management directly to patients in the operating room.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$28.89 million
Price / Sales0.01
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Imris (OTCMKTS:IMRSQ) Frequently Asked Questions
What is Imris' stock symbol?
Imris trades on the OTCMKTS under the ticker symbol "IMRSQ."
How were Imris' earnings last quarter?
Imris Inc. (OTCMKTS:IMRSQ) released its earnings results on Tuesday, October, 28th. The company reported ($0.16) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.06. The company earned $6.90 million during the quarter, compared to the consensus estimate of $8.07 million. View Imris' Earnings History.
Who are some of Imris' key competitors?
Some companies that are related to Imris include BG Medicine (BGMD), China Gerui Advanced Materials Group (CHOPF), Seal123 (WTSLQ), Glori Energy (GLRI), Prospect Global Resources (PGRX), QF Liquidation (QTWWQ), Deer Consumer Products (DEER), M Pharmaceutical (MPHMF), Azure Midstream Pa Com Unit Ltd Partner Int (AZURQ), Roust (CEDCQ), James River Coal (JRCCQ), Violin Memory (VMEMQ), Noranda Aluminum (NORNQ), DS Healthcare Group (DSKX), Erickson (EACIQ), Trimedyne (TMED), Ignite Restaurant Group (IRGTQ) and First NBC Bank (FNBC).
Who are Imris' key executives?
Imris' management team includes the folowing people:
- H. David Graves, Chairman of the Board
- Jay D. Miller, President, Chief Executive Officer, Chief Operating Officer
- Meir Dahan, Executive Vice President - Research and Development, Chief Technology Officer
- R. Stephen Armstrong, Independent Director (Age 64)
- Carey Diamond, Independent Director
- William C. Fraser, Independent Director
- James B. Hickey Jr., Independent Director (Age 58)
- Blaine Hobson, Independent Director
How do I buy Imris stock?
Shares of Imris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Imris' stock price today?
One share of Imris stock can currently be purchased for approximately $0.00.
How big of a company is Imris?
Imris has a market capitalization of $219,100.00 and generates $28.89 million in revenue each year.
How can I contact Imris?
Imris' mailing address is 100-1370 Sony Pl, WINNIPEG, MB R3T 1N5, Canada. The company can be reached via phone at +1-204-4807090 or via email at [email protected]
MarketBeat Community Rating for Imris (IMRSQ)MarketBeat's community ratings are surveys of what our community members think about Imris and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Imris (OTCMKTS:IMRSQ) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Imris (OTCMKTS:IMRSQ) Earnings History and Estimates Chart
Imris (OTCMKTS IMRSQ) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/4/2015||Q414||($0.07)||($0.13)||$13.10 million||$9.60 million||View||N/A|
|10/28/2014||Q314||($0.10)||($0.16)||$8.07 million||$6.90 million||View||N/A|
|5/13/2014||Q114||($0.10)||($0.15)||$8.83 million||$8.15 million||View||N/A|
|8/13/2013||Q213||($0.16)||($0.16)||$10.12 million||$10.23 million||View||N/A|
|11/8/2012||Q312||($0.14)||($0.19)||$12.72 million||$11.57 million||View||N/A|
Imris (OTCMKTS:IMRSQ) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Imris (OTCMKTS:IMRSQ)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Imris (OTCMKTS IMRSQ)
No insider trades for this company have been tracked by MarketBeat.com
Imris (OTCMKTS IMRSQ) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Imris (OTCMKTS:IMRSQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Imris (OTCMKTS IMRSQ) Stock Chart for Tuesday, December, 12, 2017